Eli Lilly Exec Heads to Harvard Med School
noreply@blogger.com (RCoffield@fsblaw.com)
William Chin, Eli Lilly’s senior VP for discovery and clinical research, is going to take a newly created job at Harvard Medical School.
He’ll be the “executive dean for research.” It sounds like at least part of his job will be figuring out how Harvard researchers should interact with industry, as well as working to move research from the lab to the clinic. Here’s a key chunk of a letter posted online today by the med school’s senior dean:
One of Bills highest priorities will be to conceptualize and develop new research initiatives, such as the therapeutics discovery initiative, envisioned as a focused and innovative effort to bring together the enormous expertise of our community in order to find effective new ways for transforming the worlds most vital biomedical research into therapies that can directly improve human health. Bill will also develop a coherent strategy for the Schools scientific interactions with industry, ensuring it is both aligned with the HMS Faculty Policy on Conflicts of Interest and Commitment and is capable of advancing critical unmet needs.
Chin was a professor of medicine at Harvard before he joined Lilly in 1999, according to his bio on the company’s Web site. He also got his […]
Read more this great post here
